Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae
10.1186/s13756-015-0055-6
Saved in:
Main Authors: | Harris P.N.A., Yin M., Jureen R., Chew J., Ali J., Paynter S., Paterson D.L., Tambyah P.A. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
BioMed Central Ltd.
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/144022 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
by: Anucha Apisarnthanarak, et al.
Published: (2018) -
In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae
by: Thidarat Netikul, et al.
Published: (2018) -
Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?
by: Donaldson, A.D., et al.
Published: (2011) -
Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?
by: Donaldson, A.D., et al.
Published: (2014) -
Genomic epidemiology of carbapenem-resistant Klebsiella in Qatar: emergence and dissemination of hypervirulent Klebsiella pneumoniae sequence type 383 strains
by: Tsui, Clement Kin-Ming, et al.
Published: (2023)